- Home
- CCG vs PRLD Comparison
CCG vs PRLD Comparison
Compare CCG & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- PRLD
- Stock Information
- Founded
- CCG 2014
- PRLD 2016
- Country
- CCG China
- PRLD United States
- Employees
- CCG N/A
- PRLD N/A
- Industry
- CCG
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- CCG
- PRLD Health Care
- Exchange
- CCG Nasdaq
- PRLD Nasdaq
- Market Cap
- CCG 87.9M
- PRLD 73.7M
- IPO Year
- CCG N/A
- PRLD 2020
- Fundamental
- Price
- CCG $0.95
- PRLD $0.80
- Analyst Decision
- CCG
- PRLD Strong Buy
- Analyst Count
- CCG 0
- PRLD 2
- Target Price
- CCG N/A
- PRLD $4.50
- AVG Volume (30 Days)
- CCG 697.9K
- PRLD 206.1K
- Earning Date
- CCG 03-28-2025
- PRLD 03-10-2025
- Dividend Yield
- CCG N/A
- PRLD N/A
- EPS Growth
- CCG N/A
- PRLD N/A
- EPS
- CCG N/A
- PRLD N/A
- Revenue
- CCG $475,831,129.00
- PRLD $7,000,000.00
- Revenue This Year
- CCG N/A
- PRLD N/A
- Revenue Next Year
- CCG $1.24
- PRLD N/A
- P/E Ratio
- CCG N/A
- PRLD N/A
- Revenue Growth
- CCG 5.20
- PRLD N/A
- 52 Week Low
- CCG $0.56
- PRLD $0.63
- 52 Week High
- CCG $3.81
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- CCG 45.56
- PRLD 52.89
- Support Level
- CCG $0.89
- PRLD $0.71
- Resistance Level
- CCG $1.26
- PRLD $0.76
- Average True Range (ATR)
- CCG 0.10
- PRLD 0.08
- MACD
- CCG -0.01
- PRLD 0.02
- Stochastic Oscillator
- CCG 14.63
- PRLD 73.78
About CCG Cheche Group Inc.
Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.